ENIGMA-TRS 2 is a global, randomized, double-blind, placebo-controlled 12-week Phase III clinical study designed to enroll at least 400 patients; topline results are expected by Q4 2026Evenamide is a ...

The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

Trypanosomatids are parasites that can result in more than 1 billion potentially fatal infections per year globally. In Africa, Human African Trypanosomiasis (HAT), better known as sleeping sickness, ...

The bipolar disorder (BD) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and ...

One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, according to a new study published November 5, 2025, in npj Precision Oncology ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of dementia. You will find what these drugs treat, the evidence connecting them to ...

Dementia is a highly prevalent condition, affecting 57 million people worldwide, with nearly 10 million new cases each year, ...

Morgan Stanley initiated coverage of MapLight Therapeutics (MPLT) with an Overweight rating and $34 price target The company’s lead asset, ML007-C-MA, has “best in class potential” in the greater than ...

California clinics' doors are flying open, patients are lining up and ketamine is being prescribed off-label for everything ...

The investigation shows how profit-driven psychiatry and compromised regulators created a crisis of violence masked as ...